Singapore Entry Conditions Force Postponement of International Event

The entry conditions for travellers visiting Singapore range from complete entry bans for a number of countries with important pharmaceutical industries, to up to four pre-departure and on-arrival PCR tests depending on the country of departure, to 7-days or 14-days quarantines, or a mixture of various measures.

The reluctance of executives to travel to Singapore under these confusing circumstances has led to a globally imbalanced composition of registrants which would not have supported this event’s claim to be a highly performant platform for worldwide business development. The organisers have decided to postpone asiaPLX 1 Singapore to spring 2023. The exact date will be published on www.raucon.com.

asiaPLX is an Asian extension of the successful euroPLX Marketplace for Pharma Business Opportunities, the world’s oldest and most often held pharma business development partnering event. It was designed for business development professionals and introduced in 1995 by Heidelberg, Germany, based RauCon GmbH & Co. KG.

This press release is also available
in Spanish: https://www.raucon.com/…
and German: https://www.raucon.com/…